Camille L Bedrosian - Net Worth and Insider Trading
Camille L Bedrosian Net Worth
The estimated net worth of Camille L Bedrosian is at least $3 Million dollars as of 2025-05-13. Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc and owns about 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $2 Million. Camille L Bedrosian is also the Chief Medical Officer of Amylyx Pharmaceuticals Inc and owns about 194,375 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $872,744. Details can be seen in Camille L Bedrosian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Camille L Bedrosian has not made any transactions after 2025-03-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Camille L Bedrosian
Camille L Bedrosian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Camille L Bedrosian owns 4 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Crinetics Pharmaceuticals Inc (CRNX) , and ARIAD Pharmaceuticals Inc (ARIA) among others .
Click here to see the complete history of Camille L Bedrosian’s form 4 insider trades.
Insider Ownership Summary of Camille L Bedrosian
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | EVP and Chief Medical Officer |
| CRNX | Crinetics Pharmaceuticals Inc | 2020-09-01 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2007-04-16 | VP & Chief Medical Officer |
 | | 2020-12-09 | director |
Camille L Bedrosian Latest Holdings Summary
Camille L Bedrosian currently owns a total of 2 stocks. Among these stocks, Camille L Bedrosian owns 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2023, with a value of $2 Million and a weighting of 65.46%. Camille L Bedrosian also owns 194,375 shares of Amylyx Pharmaceuticals Inc (AMLX) as of March 31, 2025, with a value of $872,744 and a weighting of 34.54%.
Latest Holdings of Camille L Bedrosian
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | 46,720 | 35.40 | 1,653,888 |
| AMLX | Amylyx Pharmaceuticals Inc | 2025-03-31 | 194,375 | 4.49 | 872,744 |
Holding Weightings of Camille L Bedrosian
Camille L Bedrosian Form 4 Trading Tracker
According to the SEC Form 4 filings, Camille L Bedrosian has made a total of 11 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 3,881 shares on March 1, 2023, which brought Camille L Bedrosian around $175,615.
According to the SEC Form 4 filings, Camille L Bedrosian has made a total of 3 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 12,425 shares on March 31, 2025, which brought Camille L Bedrosian around $43,115.
Insider Trading History of Camille L Bedrosian
- 1
Camille L Bedrosian Trading Performance
Camille L Bedrosian Ownership Network
Ownership Network List of Camille L Bedrosian
Ownership Network Relation of Camille L Bedrosian
Camille L Bedrosian Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , Chief Financial Officer Howard Horn , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Camille L Bedrosian made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 218,434 shares made by Emil D Kakkis , a net sale of 11,441 shares made by Eric Crombez , and a net sale of 29,398 shares made by Karah Herdman Parschauer .
In summary, during the past 3 months, insiders sold 162,299 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 162,299 shares. During the past 18 months, 341,469 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 341,469 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Camille L Bedrosian Mailing Address
Above is the net worth, insider trading, and ownership report for Camille L Bedrosian. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Camille L Bedrosian's mailing address is: Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
